Pradžia › Kartotinė mieloma
Kartotinė mieloma klinikiniai tyrimai JAV ieško dalyvių
239 tyrimai dėl Kartotinė mieloma ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY60 tyrimai
- Boston, MA42 tyrimai
- Atlanta, GA41 tyrimas
- Houston, TX38 tyrimai
- Durham, NC37 tyrimai
- Nashville, TN32 tyrimai
- Denver, CO27 tyrimai
- Rochester, MN24 tyrimai
- St. Louis, MO24 tyrimai
- Columbus, OH24 tyrimai
- Baldwin Park, CA23 tyrimai
- Chicago, IL22 tyrimai
- Seattle, WA22 tyrimai
- Washington, DC22 tyrimai
- Edison, NJ22 tyrimai
- Miami, FL21 tyrimas
- Salt Lake City, UT21 tyrimas
- Charlotte, NC21 tyrimas
- Milwaukee, WI21 tyrimas
- Queens, NY20 tyrimai
- Detroit, MI19 tyrimai
- Jacksonville, FL18 tyrimai
- Birmingham, AL18 tyrimai
- Los Angeles, CA17 tyrimai
- Dallas, TX17 tyrimai
- Cincinnati, OH17 tyrimai
- Cleveland, OH16 tyrimai
- Phoenix, AZ16 tyrimai
- Philadelphia, PA16 tyrimai
- Omaha, NE16 tyrimai
- Tampa, FL15 tyrimai
- Cedar Rapids, IA15 tyrimai
- San Francisco, CA15 tyrimai
- Irvine, CA14 tyrimai
- Winston-Salem, NC14 tyrimai
- New Rochelle, NY14 tyrimai
- New Haven, CT14 tyrimai
- Clifton, NJ14 tyrimai
- Portland, OR13 tyrimai
- Indianapolis, IN13 tyrimai
Pagal valstiją
- Aidahas3 tyrimai
- Ajova17 tyrimai
- Alabama22 tyrimai
- Arizona28 tyrimai
- Arkansas9 tyrimai
- Delaveras4 tyrimai
- Džordžija49 tyrimai
- Florida55 tyrimai
- Ilinoisas31 tyrimas
- Indianas19 tyrimai
- Kalifornija70 tyrimai
- Kanzasas12 tyrimai
- Kentukis15 tyrimai
- Koloradas37 tyrimai
- Kolumbijos apskritis10 tyrimai
- Konektikutas18 tyrimai
- Luiziana9 tyrimai
- Masčusetsas44 tyrimai
- Menas3 tyrimai
- Merilendas25 tyrimai
- Minesota30 tyrimai
- Misūris27 tyrimai
- Mičiganas26 tyrimai
- Montana4 tyrimai
- Naujoji Hampšyras4 tyrimai
- Nebraska18 tyrimai
- New Jersey38 tyrimai
- New Mexico5 tyrimai
- New York75 tyrimai
- North Carolina52 tyrimai
- North Dakota5 tyrimai
- Ohio46 tyrimai
- Oklahoma3 tyrimai
- Oregon20 tyrimai
- Pennsylvania23 tyrimai
- Rhode Island6 tyrimai
- South Carolina9 tyrimai
- South Dakota3 tyrimai
- Tennessee32 tyrimai
- Texas53 tyrimai
- Utah21 tyrimas
- Virginia20 tyrimai
- Washington30 tyrimai
- West Virginia3 tyrimai
- Wisconsin28 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06904066A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07582432A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07589634A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06679829Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06630104Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06948084The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07285044A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT05519085SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07850284A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07409246A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07391657A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT05652335A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT04973605Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-09-28 · NCT02682667Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Renkami dalyviai2 fazė
Amžius nuo 18 iki 72 · Visoms lytims · Atnaujinta 2026-09-28 · NCT03412877Tissue Collection for Studies of Lymph Cancer
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT01676805A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07518186A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06500884A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07073547A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06768489Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07609940A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07149857A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07258511Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06052826A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT04634552Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.